title: Several conserved positively charged amino acids in OATP1B1 are involved in binding or translocation of different substrates.
abstract: OATP1B1 and 1B3 are related transporters mediating uptake of numerous compounds into hepatocytes. A putative model of OATP1B3 with a "positive binding pocket" containing conserved positively charged amino acids was predicted (Meier-Abt et al. J Membr Biol 208:213-227, 2005). Based on this model, we tested the hypothesis that these positive amino acids are important for OATP1B1 function. We made mutants and measured surface expression and uptake of estradiol-17β-glucuronide, estrone-3-sulfate and bromosulfophthalein in HEK293 cells. Two of the mutants had low surface expression levels: R181K at 10% and R580A at 30% of wild-type OATP1B1. A lysine at position 580 (R580K) rescued the expression of R580A. Mutations of several amino acids resulted in substrate-dependent effects. The largest changes were seen for estradiol-17β-glucuronide, while estrone-3-sulfate and bromosulfophthalein transport were less affected. The wild-type OATP1B1 K (m) value for estradiol-17β-glucuronide of 5.35 ± 0.54 μM was increased by R57A to 30.5 ± 3.64 μM and decreased by R580K to 0.52 ± 0.18 μM. For estrone-3-sulfate the wild-type high-affinity K (m) value of 0.55 ± 0.12 μM was increased by K361R to 1.8 ± 0.47 μM and decreased by R580K to 0.1 ± 0.04 μM. In addition, R580K reduced the V (max) values for all three substrates to <25% of wild-type OATP1B1. Mutations at intracellular K90, H92 and R93 mainly affected V (max) values for estradiol-17β-glucuronide uptake. In conclusion, the conserved amino acids R57, K361 and R580 seem to be part of the substrate binding sites and/or translocation pathways in OATP1B1.
authors.affiliation: Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
authors.forename: Yi M
authors.initials: YM
authors.lastname: Weaver
authors.forename: Bruno
authors.initials: B
authors.lastname: Hagenbuch
mesh_terms: D000595:Amino Acid Sequence; D000596:Amino Acids / Q000737:chemistry* / Q000378:metabolism*; D017124:Conserved Sequence; D057809:HEK293 Cells; D006801:Humans; D027381:Liver-Specific Organic Anion Transporter 1; D008969:Molecular Sequence Data; D027361:Organic Anion Transporters / Q000737:chemistry* / Q000378:metabolism*; D011485:Protein Binding; D021381:Protein Transport / Q000502:physiology*; D055672:Static Electricity; D013329:Structure-Activity Relationship
chemical_list: D000596:Amino Acids; D027381:Liver-Specific Organic Anion Transporter 1; D027361:Organic Anion Transporters; C503999:SLCO1B1 protein, human
references.citation: Clin Pharmacol Ther. 2003 Jun;73(6):554-65
references.pmid: 12811365
references.citation: Science. 2006 May 5;312(5774):741-4
references.pmid: 16675700
references.citation: Clin Pharmacokinet. 2008;47(7):463-74
references.pmid: 18563955
references.citation: J Biol Chem. 2002 Nov 8;277(45):43058-63
references.pmid: 12196548
references.citation: Br J Pharmacol. 2010 Feb 1;159(3):698-708
references.pmid: 20100277
references.citation: Eur J Pharmacol. 2008 Apr 14;584(1):57-65
references.pmid: 18321482
references.citation: J Membr Biol. 2005 Dec;208(3):213-27
references.pmid: 16648940
references.citation: Clin Pharmacol Ther. 2006 May;79(5):427-39
references.pmid: 16678545
references.citation: Hepatol Res. 2004 Oct;30(2):91-95
references.pmid: 15519273
references.citation: Biochem Biophys Res Commun. 2000 Jun 24;273(1):251-60
references.pmid: 10873595
references.citation: J Biol Chem. 1999 Jun 11;274(24):17159-63
references.pmid: 10358072
references.citation: Am J Physiol Gastrointest Liver Physiol. 2008 Apr;294(4):G1052-9
references.pmid: 18308854
references.citation: J Pharmacol Exp Ther. 2004 Oct;311(1):139-46
references.pmid: 15159445
references.citation: J Biol Chem. 2004 Feb 20;279(8):7213-22
references.pmid: 14660639
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2006 Mar;372(6):432-43
references.pmid: 16525793
references.citation: Science. 2003 Aug 1;301(5633):616-20
references.pmid: 12893936
references.citation: Gastroenterology. 2001 Feb;120(2):525-33
references.pmid: 11159893
references.citation: Pharmacogenet Genomics. 2007 Oct;17(10):873-83
references.pmid: 17885626
references.citation: Protein Sci. 2009 Nov;18(11):2298-306
references.pmid: 19760661
references.citation: Pharmacogenet Genomics. 2005 Jul;15(7):513-22
references.pmid: 15970799
references.citation: Clin Pharmacol Ther. 2008 Jun;83(6):815-7
references.pmid: 18043684
references.citation: Am J Physiol Gastrointest Liver Physiol. 2000 Jan;278(1):G156-64
references.pmid: 10644574
references.citation: Science. 2003 Aug 1;301(5633):610-5
references.pmid: 12893935
references.citation: Lung Cancer. 2008 Jan;59(1):69-75
references.pmid: 17766002
references.citation: Xenobiotica. 2008 Jul;38(7-8):778-801
references.pmid: 18668430
references.citation: Drug Metab Dispos. 2007 Aug;35(8):1308-14
references.pmid: 17470528
references.citation: Endocrinology. 2008 Sep;149(9):4695-701
references.pmid: 18499754
references.citation: Pharmacogenetics. 2004 Jul;14(7):429-40
references.pmid: 15226675
references.citation: Clin Exp Pharmacol Physiol. 2007 Dec;34(12):1240-4
references.pmid: 17973861
references.citation: Pflugers Arch. 2004 Feb;447(5):653-65
references.pmid: 14579113
references.citation: Pharmacogenet Genomics. 2008 Jul;18(7):559-68
references.pmid: 18551036
references.citation: J Biol Chem. 1999 Dec 24;274(52):37161-8
references.pmid: 10601278
references.citation: Gastroenterology. 2001 Jun;120(7):1689-99
references.pmid: 11375950
references.citation: Pharm Res. 2001 Sep;18(9):1262-9
references.pmid: 11683238
references.citation: Biochemistry. 2002 Jul 23;41(29):9215-21
references.pmid: 12119036
references.citation: Drug Metab Dispos. 2005 Mar;33(3):434-9
references.pmid: 15608127
references.citation: J Pharmacol Exp Ther. 2009 May;329(2):551-7
references.pmid: 19244099
references.citation: J Pharmacol Exp Ther. 2002 Aug;302(2):804-13
references.pmid: 12130747
references.citation: Pharmacogenet Genomics. 2008 Oct;18(10):921-6
references.pmid: 18794729
references.citation: J Biol Chem. 2001 Sep 21;276(38):35669-75
references.pmid: 11477075
references.citation: J Pharmacol Exp Ther. 2003 Jan;304(1):223-8
references.pmid: 12490595
references.citation: Pharmacogenetics. 2004 Nov;14(11):749-57
references.pmid: 15564882
references.citation: J Biol Chem. 2001 Mar 30;276(13):9626-30
references.pmid: 11134001